CAS 1018675-35-8

Formula: C21H21F3N4O3

InChI: InChI=1S/C21H21F3N4O3/c1-13-20(31)28(8-7-25-19(30)12-29)18-10-16(5-6-17(18)27-13)26-11-14-3-2-4-15(9-14)21(22,23)24/h2-6,9-10,26,29H,7-8,11-12H2,1H3,(H,25,30)

InChI key: HRAQDVZJYIAWOV-UHFFFAOYSA-N

SMILES: CC1=NC2=C(C=C(C=C2)NCC3=CC(=CC=C3)C(F)(F)F)N(C1=O)CCNC(=O)CO

CVT-12012

CAS: 1018675-35-8

CVT-12012

Formula: C₂₁H₂₁F₃N₄O₃

Purity: 99.5%

Molecular weight: 434.41

Ref: 54-BUP04973

CVT-12012

CAS: 1018675-35-8

Formula: C₂₁H₂₁F₃N₄O₃

Purity: 99%

Molecular weight: 434.4116

Ref: IN-DA01EOCM

CVT-12012

CAS: 1018675-35-8

CVT-12012 is an orally bioavailable inhibitor of stearoyl-CoA desaturase (SCD; IC50 = 6.1 nM in HepG2 cells).

Formula: C₂₁H₂₁F₃N₄O₃

Purity: 99.56%

Color and Shape: Solid

Molecular weight: 434.4116

Ref: TM-T6412

CVT-12012

CAS: 1018675-35-8

CVT-12012 is an endogenous, unsaturated fatty acid that interacts with lymphoblastic leukemia cells. It has been found to inhibit the growth of leukemia cells in vitro and reduce tumor size in mice. CVT-12012 is thought to work by inhibiting fatty acid synthesis and increasing the levels of endogenous unsaturated fatty acids.

Formula: C₂₁H₂₁F₃N₄O₃

Purity: Min. 95%

Molecular weight: 434.41 g/mol

Ref: 3D-TQB67535